254 related articles for article (PubMed ID: 34361040)
1. The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative.
Kolaczynska KE; Thomann J; Hoener MC; Liechti ME
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361040
[TBL] [Abstract][Full Text] [Related]
2. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
Rickli A; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
[TBL] [Abstract][Full Text] [Related]
3. Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells.
Simmler LD; Liechti ME
Curr Top Behav Neurosci; 2017; 32():49-72. PubMed ID: 27272068
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
Han DD; Gu HH
BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
[TBL] [Abstract][Full Text] [Related]
5. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
Halberstadt AL; Brandt SD; Walther D; Baumann MH
Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
[TBL] [Abstract][Full Text] [Related]
6. The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.
Gannon BM; Baumann MH; Walther D; Jimenez-Morigosa C; Sulima A; Rice KC; Collins GT
Neuropsychopharmacology; 2018 Nov; 43(12):2399-2407. PubMed ID: 30305739
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedrone.
McLaughlin G; Morris N; Kavanagh PV; Power JD; Dowling G; Twamley B; O'Brien J; Talbot B; Walther D; Partilla JS; Baumann MH; Brandt SD
Drug Test Anal; 2017 Mar; 9(3):358-368. PubMed ID: 27524685
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.
Solis E
Curr Top Behav Neurosci; 2017; 32():73-92. PubMed ID: 27677783
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-DMAR, and 3,4-DMAR.
Rickli A; Kolaczynska K; Hoener MC; Liechti ME
Neurotoxicology; 2019 May; 72():95-100. PubMed ID: 30776375
[TBL] [Abstract][Full Text] [Related]
10. Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.
Negus SS; Banks ML
Curr Top Behav Neurosci; 2017; 32():119-131. PubMed ID: 27696217
[TBL] [Abstract][Full Text] [Related]
11. Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomers.
McLaughlin G; Morris N; Kavanagh PV; Power JD; Dowling G; Twamley B; O'Brien J; Hessman G; Murphy B; Walther D; Partilla JS; Baumann MH; Brandt SD
Drug Test Anal; 2017 Mar; 9(3):347-357. PubMed ID: 28103426
[TBL] [Abstract][Full Text] [Related]
12. Structure-Activity Relationships for a Recently Controlled Synthetic Cathinone Dopamine Transporter Reuptake Inhibitor: α-Pyrrolidinohexiophenone (α-PHP).
Davies RA; Nguyen VT; Eltit JM; Glennon RA
ACS Chem Neurosci; 2023 Jul; 14(14):2527-2536. PubMed ID: 37406364
[TBL] [Abstract][Full Text] [Related]
13. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
[TBL] [Abstract][Full Text] [Related]
14. Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors.
He R; Kurome T; Giberson KM; Johnson KM; Kozikowski AP
J Med Chem; 2005 Dec; 48(25):7970-9. PubMed ID: 16335921
[TBL] [Abstract][Full Text] [Related]
15. Using Ca
Steele TWE; Eltit JM
Psychopharmacology (Berl); 2019 Mar; 236(3):973-988. PubMed ID: 30448989
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.
Greiner E; Boos TL; Prisinzano TE; De Martino MG; Zeglis B; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
J Med Chem; 2006 Mar; 49(5):1766-72. PubMed ID: 16509591
[TBL] [Abstract][Full Text] [Related]
17. Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.
Simmler LD; Rickli A; Hoener MC; Liechti ME
Neuropharmacology; 2014 Apr; 79():152-60. PubMed ID: 24275046
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
[TBL] [Abstract][Full Text] [Related]
19. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
[TBL] [Abstract][Full Text] [Related]
20. Neuropharmacology of Synthetic Cathinones.
Baumann MH; Walters HM; Niello M; Sitte HH
Handb Exp Pharmacol; 2018; 252():113-142. PubMed ID: 30406443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
